Resultats de la cerca - C-C Liu
- Mostrar 1 - 20 resultats de 23
- Anar a la pàgina següent
-
1
-
2
-
3
-
4
Tumour-associated antigens and their anti-cancer applications per C.-C. Liu, Hui Yang, Ran Zhang, Jianmei Zhao, D Hao
Publicat 2016Revisão -
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
Perforin, a cytotoxic molecule which mediates cell necrosis, is not required for the early control of mycobacterial infection in mice per Pairote Laochumroonvorapong, Junjie Wang, C C Liu, Weimin Ye, André L. Moreira, Keith B. Elkon, Victoria H. Freedman, Gilla Kaplan
Publicat 1997Artigo -
15
-
16
-
17
Aberrant expression of microRNAs as biomarker for schizophrenia: from acute state to partial remission, and from peripheral blood to cortical tissue per C-Y Lai, Soo‐Youn Lee, Elizabeth Scarr, Yanhong Yu, Yi‐Ting Lin, Chih‐Min Liu, Tzung‐Jeng Hwang, Ming H. Hsieh, C-C Liu, Yi‐Ling Chien, Madhara Udawela, Andrew S. Gibbons, Ian Everall, Hai‐Gwo Hwu, Brian Dean, Wei J. Chen
Publicat 2016Artigo -
18
Targeting MYCN-expressing triple-negative breast cancer with BET and MEK inhibitors per Johanna M. Schafer, Brian D. Lehmann, Paula I. González-Ericsson, Clayton B. Marshall, J. Scott Beeler, Lindsay N. Redman, Hailing Jin, Violeta Sánchez, Matthew C. Stubbs, Peggy Scherle, Kimberly N. Johnson, Quanhu Sheng, Joseph T. Roland, Joshua A. Bauer, Yu Shyr, Bapsi Chakravarthy, Bret C. Mobley, Scott W. Hiebert, Justin M. Balko, Melinda E. Sanders, Phillip C.C. Liu, Jennifer A. Pietenpol
Publicat 2020Artigo -
19
INCB054828 (pemigatinib), a potent and selective inhibitor of fibroblast growth factor receptors 1, 2, and 3, displays activity against genetically defined tumor models per Phillip C.C. Liu, Holly K. Koblish, Liangxing Wu, Kevin Bowman, Sharon Diamond, Darlise DiMatteo, Yue Zhang, Michael Hansbury, Mark Rupar, Xiaoming Wen, Paul Collier, Patricia Feldman, Ronald M. Klabe, Krista Burke, Maxim Soloviev, Christine Gardiner, Xin He, Alla Volgina, Maryanne Covington, Bruce Ruggeri, Richard Wynn, Timothy C. Burn, Peggy Scherle, Swamy Yeleswaram, Wenqing Yao, Reid Huber, Gregory Hollis
Publicat 2020Artigo -
20
Identification of ADAM10 as a major source of HER2 ectodomain sheddase activity in HER2 overexpressing breast cancer cells per Phillip C.C. Liu, Xiangdong Liu, Yanlong Li, Maryanne Covington, Richard Wynn, Reid Huber, Milton C. Hillman, Gengjie Yang, D. Christian Ellis, Cindy Marando, Kamna Katiyar, Jodi D. Bradley, Kenneth Abremski, Mark Stow, Mark Rupar, Jin‐Cong Zhuo, Yunlong Li, Qiyan Lin, David Burns, Meizhong Xu, Colin Zhang, Ding‐Quan Qian, Chunhong He, Vaqar Sharief, Lingkai Weng, Costas Agrios, Eric Shi, Brian Metcalf, Robert Newton, Steven Friedman, Wenqing Yao, Peggy Scherle, Gregory Hollis, Timothy C. Burn
Publicat 2006Artigo
Eines de cerca:
Matèries relacionades
Biology
Biochemistry
Immunology
Cell biology
Genetics
Molecular biology
Gene
Cytotoxic T cell
In vitro
Medicine
Cancer research
Internal medicine
Perforin
Immune system
Antigen
Cancer
Apoptosis
CD8
DNA fragmentation
Ecology
Fragmentation (computing)
Heat shock protein
In vivo
Interleukin 21
Lymphokine-activated killer cell
Pharmacology
Programmed cell death
Receptor
Breast cancer
CTL*